SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-039672
Filing Date
2018-06-13
Accepted
2018-06-12 20:20:19
Documents
3
Period of Report
2018-06-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CORRESP a18-13811_148k.htm 8-K 21226
2 EX-99.1 a18-13811_14ex99d1.htm EX-99.1 16082
3 GRAPHIC g1381114mmi001.jpg GRAPHIC 4413
  Complete submission text file 0001104659-18-039672.txt   44643
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 18895661
SIC: 2834 Pharmaceutical Preparations